Saunders J B, Latt N
Centre for Drug and Alcohol Studies, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia.
Baillieres Clin Gastroenterol. 1993 Sep;7(3):555-79. doi: 10.1016/0950-3528(93)90002-a.
Although mortality from alcoholic liver disease has declined in some Western countries in recent years, elsewhere it is increasing and overall it remains a major health problem. Deaths are predominantly seen in patients with alcoholic hepatitis or cirrhosis, and when they occur in patients with fatty liver are usually unrelated to liver disease. Progression to cirrhosis is correlated with the severity of fatty liver and particularly with the presence of alcoholic hepatitis. Mortality from cirrhosis is strongly correlated with per capita alcohol consumption. The decline in cirrhosis mortality rates seen recently is related in part to decreases in per capita consumption, but probably also to the growth of self-help organizations which facilitate abstinence from alcohol. Recent studies suggest there is not an invariable dose-response relationship between alcohol intake and the severity of liver disease and that alcohol has a permissive effect which allows other aetiological factors to operate. Factors that influence susceptibility to alcoholic liver disease include gender (women develop alcoholic cirrhosis more readily than men), concomitant hepatitis C infection and possibly hepatitis B infection. It is uncertain whether HLA status or immune mechanisms are implicated. The systematic use of screening tests for hazardous consumption combined with early intervention therapies offers a good prospect of reducing morbidity and mortality from alcoholic liver disease.
近年来,尽管酒精性肝病导致的死亡率在一些西方国家有所下降,但在其他地区却呈上升趋势,总体而言,它仍是一个重大的健康问题。死亡主要发生在酒精性肝炎或肝硬化患者中,而在脂肪肝患者中发生的死亡通常与肝脏疾病无关。进展为肝硬化与脂肪肝的严重程度相关,尤其是与酒精性肝炎的存在相关。肝硬化导致的死亡率与人均酒精消费量密切相关。最近肝硬化死亡率的下降部分与人均消费量的减少有关,但可能也与促进戒酒的自助组织的增多有关。最近的研究表明,酒精摄入量与肝脏疾病严重程度之间不存在一成不变的剂量反应关系,而且酒精具有一种促进作用,使其他病因因素得以发挥作用。影响酒精性肝病易感性的因素包括性别(女性比男性更容易发展为酒精性肝硬化)、丙型肝炎病毒合并感染,可能还有乙型肝炎病毒感染。目前尚不确定人类白细胞抗原(HLA)状态或免疫机制是否与之有关。系统地使用针对有害饮酒的筛查测试并结合早期干预治疗,有望降低酒精性肝病的发病率和死亡率。